HAS2 splicing variant HOEFC11: a target in chronic renal failure, inflammatory diseases and myocardial ischemia
    2.
    发明授权
    HAS2 splicing variant HOEFC11: a target in chronic renal failure, inflammatory diseases and myocardial ischemia 失效
    HAS2剪接变体HOEFC11:慢性肾功能衰竭,炎性疾病和心肌缺血的靶标

    公开(公告)号:US06350446B1

    公开(公告)日:2002-02-26

    申请号:US09385174

    申请日:1999-08-30

    IPC分类号: A61K3843

    CPC分类号: C12N9/1051 A61K38/00

    摘要: HOEFC11 polypeptides and polynucleotides and methods for producing such polypeptides by recombinant techniques are disclosed. Also disclosed are methods for utilizing HOEFC11 polypeptides and polynucleotides in the design of protocols for the treatment of chronic renal failure, inflammatory diseases, myocardial ischemia, cancer, rheumatoid arthritis, cirrhotic liver disease, among others, and diagnostic assays for such conditions.

    摘要翻译: 公开了HOEFC11多肽和多核苷酸以及通过重组技术产生此类多肽的方法。 还公开了在设计用于治疗慢性肾功能衰竭,炎性疾病,心肌缺血,癌症,类风湿性关节炎,肝硬化肝病等的方案中用于HOEFC11多肽和多核苷酸的方法以及用于这些病症的诊断测定法。